Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carmelo Graffagnino, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikum Leipzig
Liebigstraße 22a, Leipzig, Germany
- Universitatsklinikum Erlangen
Erlangen, Germany
- Universitatsklinikum Heidelberg
Heidelberg, Germany
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- the Queens Medical Center
Honolulu, Hawaii, United States
- the John Hopkins Hospital
Baltimore, Maryland, United States
- Maine Medical Center
Portland, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Columbia University Medical Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Guilford Neurologic - Moses H Cone Health System
Greensboro, North Carolina, United States
- Cleveland Clinic Hospitals
Cleveland, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Thomas Jefferson University Stroke Research
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- the University Health Science Center at S.A.
San Antonio, Texas, United States
- Intermountain Medical Center
Murray, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 30 Apr 2010
- Completion
- 30 Apr 2010
- Last update posted
- 29 Aug 2014
- Registered enrollment
- 37
- Registry id
- NCT00666328
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.